Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52- deficient cells

Immunology

Volumn 95, Issue 3, 1998, Pages 427-436

  Rowan, W ^a   Tite, J ^a   Topley, P ^a   Brett, S J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD19 ANTIGEN; CD20 ANTIGEN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN M; LEUKOCYTE ANTIGEN; LEUKOCYTE CD52 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, B-CELL; TUMOR CELLS, CULTURED;

EID: 0031790767     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00615.x     Document Type: Article

References (34)

1. HALE G., XIA M-G., TIGHE H.P., DYER M.J.S. & WALDMANN H. (1988) The CAMPATH-1 antigen (CDw52). Tissue Antigens 35, 118.
2. XIA M-Q., TONE M., PACKMAN L., HALE G. & WALDMANN H. (1991) Characterisation of the CAMPATH-1H (CDw52) antigen, biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol 21, 1677.
3. XIA M-Q., HALE G.M., LIFELY R. et al. (1993) Structure of the CAMPATH-1H antigen a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem J 293, 633.
4. DYER M.J.S., HALE G., HAYHOE F.G.J. & WALDMANN H. (1988) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 73, 1431.
5. BINDON C.I., HALE G. & WALDMANN H. (1989) Importance of antigen specificity for complement mediated lysis by monoclonal antibodies. Eur J Immunol 18, 1507.
6. RIECHMANN L., CLARK M.R., WALDMANN H. & WINTER G. (1986) Reshaping human antibodies for therapy. Nature 332, 323.
7. HALE G., DYER M.J.S., CLARK M.R. et al. (1988) Remission induction in non-Hodgkins lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1 1394.
8. CROWE J.S., HALL V.S., SMITH M.A., COOPER H.J. & TITE J.P. (1992) Humanised monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and chinese hamster ovary cell-derived material. Clin Exp Immunol 97, 105.
9. MAPARA M.Y., BARGOU R., ZUGCK C. et al. (1993) APO-1 mediated apoptosis or proliferation in human B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 23, 703.
10. PETER M.E., DHEIN J., EHRET A. et al. (1995) Apo-1 (CD95)-dependent and -independent antigen-receptor-induced apoptosis in human T and B cell lines. Int Immunol 7, 1873.
11. ISHIGAMI T., KIM K-M., HORIGUCHI Y. et al (1992) Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J Immunol 148, 360.
12. NAKASHIMA I., PU M-Y., HAMAGUCHI M. et al. (1993) Pathway of signal delivery to murine thymocytes triggered by co-cross-linking CD3 and Thy-1 for cellular DNA fragmentation and growth inhibition. J Immunol 151, 3511.
13. ROWAN W.C., HALE G., TITE J.P. & BRETT S.J. (1994) Cross-linking of the CAMPATH-1H antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol 7, 69.
14. NACHEVA E., FISCHER P., KARPAS A. et al. (1987) Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia. Cancer Genet Cytogenet 28, 145.
15. HALE C., BARTHOLOMEW M., STABLES J., TOPLEY P. & TITE J.P. (1996) Expression of the gene for CDw52: requirements for recognition by CAMPATH-1H antibody and for the attachment of the GPI-anchor for the two closely related gene products. Immunology 88, 183.
16. HALE G., COBBOLD S.P., WALDMANN H., EASTER G., MATELSCHUK P. & COOMBS R.R.A. (1987) Isolation of low frequency class switch variants from rat hybrid myelomas. J Immunol Methods 103, 59.
17. STANWORTH D.R. & TURNER M.W. (1978) Immunoglobulins; purification and characterisation. In: Handbook of Experimental Immunology (ed. D. M. Weir), vol. 3, p. 61. Blackwell Scientific Publications, Oxford.
18. BRYSON G.J., HARMON B.V. & COLLINS R.J. (1994) A flow cytometric study of cell death: failure of some models to correlate with morphological assessment. Immunol Cell Biol 72, 35.
19. DHEIN J., WALCZAK H., BAUMIER C., DEBATIN K-M. & KRAMMER P.H. (1995) Autocrine T cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438.
20. HALE G. (1995) Synthetic peptide mimitope of CAMPATH-1H (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein. Immunotechnology 1, 175.
21. WING M.G., MOREAU T., GREENWOOD J. et al. (1996) Mechanisms of first dose cytokine release syndrome by CAMPATH-1H-involvement of CD16 (FcγRIII) and CD11a/Cd18 (LFA.1) on NK cells. J Clin Invest 98, 2819.
22. SAVILL J., FADOK V. & HASLETT C. (1993) Phagocytic recognition of cells undergoing apoptosis. Immunol Today 14, 131.
23. PAWSON R., DYER M.J., BARGE R. et al. (1997) Treatment of T cell pro-lymphocytic leukemia with human CD52 antibody. J Clin Oncol 15, 2667.
24. HASBOLD J. & KLAUS G.G.B. (1990) Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol 20, 1685.
25. SCOTT D.W., LIVNAT D., PENNELL C.A. & KENG P. (1986) Lymphoma models for B cell activation and tolerance. III cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-μ. J Exp Med 164, 156.
26. EZHEVSKY S.A., TOYOSHIMA H., HUNTER T. & SCOTT D.W. (1996) Role of cyclin A and p27 in anti-IgM-induced G1 growth arrest of murine B cell lymphomas. Molec Biol Cell 7, 553.
27. MIZUGUCHI J., YAMANASHI Y., EHARA K. et al. (1992) Tyrosine protein kinase is involved in anti-IgM-mediated signalling in BAL. 17 B lymphoma cells. J Immunol 148, 699.
28. EISCHEN C.M., WILLIAMS B.L., ZHANG W. et al. (1997) Zap70 tyrosine kinase is required for the up-regulation of Fas ligand in activation induced T cell apoptosis. J Immunol 159, 1135.
29. STEFANOVA I., HOREJSI V., ANSOTEGUI I.J., KNAPP W. & STOCKINGER H. (1991) GPI-anchored cell surface molecules complexed to protein tyrosine kinases. Science 254, 1016.
30. WALLACH D., BOLDIN M., VARFOLOMEEV E., BEYAERT K., VANDENABEELE P. & FIERS W. (1997) Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett 410, 96.
31. BRETT S.J., BAXTER G., COOPER H. et al. (1996) Emergence of CD52-, glycosylphosphatidylinositol-anchor deficient lymphocytes in rheumatoid arthritis patients following CAMPATH-1H treatment. Int Immunol 8, 325.
32. HERTENSTEIN B., WAGNER B., BUNJES D. et al. (1995) Emergence of CD52 phophatidylinositol glycan anchor deficient T lymphocytes after in vivo application of CAMPATH-1H for refractory B cell non-Hodgkins Lymphoma. Blood 86, 1487.
33. TAYLOR V., SIMS M., BRETT S.J. & FIELD M.C. (1997) Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochem J 322, 919.
34. TAKEDA J., MIYATA T., KAWAGOE K. et al. (1993) Deficiency of the GPI-anchor caused by somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobulinuria. Cell 73, 703.